Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

PET studies in dementia.

Herholz K.

Ann Nucl Med. 2003 Apr;17(2):79-89. Review.

PMID:
12790355
2.

Clinical application of positron emission tomography for diagnosis of dementia.

Ishii K.

Ann Nucl Med. 2002 Dec;16(8):515-25. Review.

PMID:
12593416
3.
4.

Positron emission tomography imaging in dementia.

Herholz K, Carter SF, Jones M.

Br J Radiol. 2007 Dec;80 Spec No 2:S160-7. doi: 10.1259/bjr/97295129. Review.

PMID:
18445746
6.

Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.

Herholz K.

Expert Rev Neurother. 2010 Nov;10(11):1667-73. doi: 10.1586/ern.10.136. Review.

PMID:
20977325
7.

Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.

Mielke R, Heiss WD.

J Neural Transm Suppl. 1998;53:237-50. Review.

PMID:
9700661
8.

Positron emission tomography imaging of regional cerebral glucose metabolism.

Alavi A, Dann R, Chawluk J, Alavi J, Kushner M, Reivich M.

Semin Nucl Med. 1986 Jan;16(1):2-34. Review.

PMID:
2935938
9.

FDG PET and differential diagnosis of dementia.

Herholz K.

Alzheimer Dis Assoc Disord. 1995 Spring;9(1):6-16. Review.

PMID:
7605624
10.

Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease.

Foster NL, Wang AY, Tasdizen T, Fletcher PT, Hoffman JM, Koeppe RA.

Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S29-36. doi: 10.1016/j.jalz.2007.10.004. Epub 2007 Dec 21. Review.

PMID:
18631997
11.

Positron emission tomography diagnosis of Alzheimer's disease.

Coleman RE.

Neuroimaging Clin N Am. 2005 Nov;15(4):837-46, x. Review.

PMID:
16443494
12.

Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects.

Heiss WD, Herholz K, Pawlik G, Hebold I, Klinkhammer P, Szelies B.

Keio J Med. 1989 Jun;38(2):111-35. Review.

13.

Positron emission tomography in the differential diagnosis of organic dementias.

Heiss WD, Kessler J, Szelies B, Grond M, Fink G, Herholz K.

J Neural Transm Suppl. 1991;33:13-9. Review.

PMID:
1753242
14.

Emission tomography in dementia.

Pakrasi S, O'Brien JT.

Nucl Med Commun. 2005 Mar;26(3):189-96. Review.

PMID:
15722899
15.

Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.

McGeer PL, Kamo H, Harrop R, Li DK, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB, et al.

CMAJ. 1986 Mar 15;134(6):597-607. Review.

16.

Positron emission tomography in dementia.

Santens P, Petit H.

Acta Neurol Belg. 1997 Sep;97(3):192-5. Review.

PMID:
9345592
17.

The role of emission tomography in dementia.

Perani D.

Ital J Neurol Sci. 1999;20(5 Suppl):S254-7. Review.

PMID:
10662962
18.

[Molecular imaging of cerebral blood flow and metabolism with SPET and PET in principal dementias].

Gerasimou G, Bostantjopoulou S, Gotzamani-Psarrakou A.

Hell J Nucl Med. 2009 Jan-Apr;12(1):79-83. Review. Greek, Modern.

PMID:
19330195
19.

Neurochemical imaging of Alzheimer's disease and other degenerative dementias.

Frey KA, Minoshima S, Kuhl DE.

Q J Nucl Med. 1998 Sep;42(3):166-78. Review.

PMID:
9796365
20.

Imaging Alzheimer's disease: clinical applications.

Minoshima S.

Neuroimaging Clin N Am. 2003 Nov;13(4):769-80. Review.

PMID:
15024960
Items per page

Supplemental Content

Write to the Help Desk